Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Ovid Therapeutics Files Quarterly Report for June 2026

Ovid Therapeutics Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the quarterly period ended June 30, 2026, disclosing the company's financial condition and operations as a non-accelerated, smaller reporting company listed on NASDAQ:OVID.

Anjali Anand | 13 August 2026

Candel Therapeutics Files Q2 2026 Form 10-Q

Candel Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing its financial condition, operational status, and risk factors as of that date.

Shwetambri Chauhan | 13 August 2026

Fate Therapeutics Files 10-Q for Quarter Ended June 30, 2026

Fate Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the fiscal quarter ended June 30, 2026, disclosing financial condition, operational risks, and share count data as of August 6, 2026.

Aakashdeep | 13 August 2026

Lifeway Foods Reports Q2 2026 Financial Results

Lifeway Foods, Inc. filed its quarterly report on Form 10-Q with the SEC on August 13, 2026, covering the three and six months ended June 30, 2026, disclosing net sales growth alongside a sharp decline in quarterly net income compared to the prior-year period.

Aakashdeep | 13 August 2026

Tapestry Annual Report Filed for Fiscal Year 2026

Tapestry, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on August 13, 2026, covering the fiscal year ended June 27, 2026.

Aakashdeep | 13 August 2026

Lifeway Foods Files 8-K With Q2 2026 Earnings Release

Lifeway Foods, Inc. filed a current report on August 13, 2026, disclosing that it issued a press release announcing financial results for the fiscal quarter ended June 30, 2026.

Manish Choudhary | 13 August 2026

Primoris Services Director Transfers Shares to Family Trust

Patricia K. Wagner, a director at Primoris Services Corp (NYSE:PRIM), filed a Form 4 on August 12, 2026, disclosing a transfer of 2,241 shares of common stock to the Wagner Family Trust on August 11, 2026, at no consideration.

Anjali Anand | 12 August 2026

Ameriprise Financial SVP Brockman Sells 472 Shares

Dawn M. Brockman, SVP and Controller at Ameriprise Financial Inc, filed a Form 4 on August 12, 2026, disclosing the sale of 472 shares of common stock on August 10, 2026.

Aakashdeep | 12 August 2026

Ameriprise Financial EVP Melloh Exercises Stock Options

Heather J. Melloh, EVP and General Counsel of Ameriprise Financial Inc, filed a Form 4 on August 12, 2026, disclosing transactions in Ameriprise Financial common stock dated August 10, 2026.

Vinay Lochav | 12 August 2026

Applied Optoelectronics CFO Sells 4,000 Shares in August 2026

Stefan J. Murry, Chief Financial Officer of Applied Optoelectronics, Inc. (NASDAQ:AAOI), filed a Form 4 on August 12, 2026, disclosing the sale of 4,000 shares of common stock on August 10, 2026.

Shwetambri Chauhan | 12 August 2026
Support

Hi! How can we help you today?

Loading…